Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

The Real World Experience Regarding the Safety of Rivaroxaban and Apixaban in Venous Thromboembolism Patients with High Bleeding Risk

Haoxu Ouyang, MD PhD, Ratesh Khillan, Nyein Htway Yu, MBBS, MD, Mohan Preet, MD

Blood (2019) 134 (Supplement_1): 4927.

https://doi.org/10.1182/blood-2019-132283

Published: 2019

Journal Articles

The Role of Demographic and Social Factors on Decision Making in Patients with Relapsed and Refractory Multiple Myeloma Treated By Ixazomib, Lenalidomide and Dexamethasone

Jiri Minarik, MD PhD, Alexandra Jungova, Jan Straub, MD, Evzen Gregora, MD, Jana Bryknarova, Blanka Nemcova, Roman Hajek, MD

Blood (2019) 134 (Supplement_1): 5832.

https://doi.org/10.1182/blood-2019-130961

Published: 2019

Journal Articles

Predictors of Transfer to Different Facility at Discharge in Patients Admitted with Hematologic Malignancy: A Nationwide Inpatient Sample (NIS) Database Analysis

Sunny R K Singh, MD, Sindhu Malapati, MD, Rohit Kumar, MD, Olekdandra Lupak, MD, Philip Kuriakose, MD

Blood (2019) 134 (Supplement_1): 2132.

https://doi.org/10.1182/blood-2019-127604

Published: 2019

Journal Articles

Management of Cerebral Vein Thrombosis in a Canadian Tertiary Hospital

Lana A Castellucci, MD, Philip Chiang

Blood (2018) 132 (Supplement 1): 2532.

https://doi.org/10.1182/blood-2018-99-118369

Published: 2018

Journal Articles

Health Care Utilization and Costs Among Patients with Chronic Myeloid Leukemia Using Tyrosine Kinase Inhibitors

Joanna C Huang, PharmD, Sudeep Karve, PhD, Sanchita Porwal, BS, Kushan Thakkar, MS, Thomas Marshall, PharmD, MS, Tanja Rosenberg, MD

Blood (2018) 132 (Supplement 1): 3537.

https://doi.org/10.1182/blood-2018-99-113809

Published: 2018

Journal Articles

Patient with Myeloma Who Develops Thrombotic Microangiopathy without Hemolysis

Juliana Alvarez Argote, MD

Blood (2018) 132 (Supplement 1): 5661.

https://doi.org/10.1182/blood-2018-99-117095

Published: 2018

Journal Articles

Assisted Administration of Subcutaneous Rituximab to the Patient's Home. Significant Reduction of Indirect Costs Incurred By Care Recipients and Unpaid Caregivers Together with a Total Adherence to the Treatment Schedule and Same Safety

Francesco Iuliano, MD, Eleonora Iuliano, MD, Marco Rossi, MD

Blood (2018) 132 (Supplement 1): 5869.

https://doi.org/10.1182/blood-2018-99-118756

Published: 2018

Journal Articles

Predictors for Recurrent 30-Day Unplanned Readmissions in Patients with Hematologic Malignancies

Blood (2017) 130 (Supplement 1): 532.

https://doi.org/10.1182/blood.V130.Suppl_1.532.532

Published: 2017

Journal Articles

Comparison of Disposition and Complications in Geriatric (≥ 65 years) and Non-Geriatric (50-64 years) Cancer Patients Receiving Hematopoietic Stem Cell Transplantation

Achuta Kumar Guddati, MD PhD, Gagan Kumar, MD MS, Robert David Lewis, MD, Iuliana Shapira, MD

Blood (2016) 128 (22): 2408.

https://doi.org/10.1182/blood.V128.22.2408.2408

Published: 2016

Journal Articles

A Rapid Desensitization Program Is a Viable Therapeutic Option in the Management of Immunomodulating Agent-Related Hypersensitivity Reactions in Patients with Plasma Cell Disorders

Jack T Seki, PharmD, Naoko Sakurai, Phm, MSc, Wallace Lam, BSc, Phm, Vesna Lukaroska, BSc, Phm, Anna Granic, BSc, Phm, Patricia Disperati, MD, Amy Tam, MD, Suzanne Trudel, MD, Donna Reece, MD

Blood (2016) 128 (22): 2411.

https://doi.org/10.1182/blood.V128.22.2411.2411

Published: 2016

Journal Articles

Risk Factors for Early Death after Immunochemotherapy in Older Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Kalyan Mantripragada, MD MPH, Jorge J Castillo, MD, Adam J Olszewski, MD

Blood (2015) 126 (23): 3914.

https://doi.org/10.1182/blood.V126.23.3914.3914

Published: 2015

Journal Articles

Examination of the Prognosis and Health-Related Quality of Life of Elderly Patients with Malignant Lymphoma

Fumihito Tajima, MD PhD, Nozomi Hamada, RN, Tetsuo Yamamoto, MD PhD, Rika Hasegawa, RN, Masae Higashimori, RN, Toshio Kawatani, MD PhD

Blood (2015) 126 (23): 5601.

https://doi.org/10.1182/blood.V126.23.5601.5601

Published: 2015

Journal Articles

Spectrum of Cerebrovascular Disease in Multiple Myeloma Patients Undergoing Chemotherapy

Archana Hinduja, MD, Kaustubh Limaye, MD, Rahul Ravilla, MD, Appalanaidu Sasapu, MD MS, Xenofon Papanikolaou, MD, Sarah Waheed, MD

Blood (2015) 126 (23): 5498.

https://doi.org/10.1182/blood.V126.23.5498.5498

Published: 2015

Journal Articles

Using the Rothman Index to Predict Discharge and Readmission Rates in an Inpatient Hematology Unit

Roger Y. Kim, BS, Xiaopan Yao, PhD, Peter Longley, RN, DNP, Joan Rimar, DNSc, RN, Chryssanthi Kournioti, MD, Alfred Ian Lee, MD PhD

Blood (2014) 124 (21): 1302.

https://doi.org/10.1182/blood.V124.21.1302.1302

Published: 2014

Journal Articles

Assisted Administration Of Subcutaneous 5-Azacytidine to The Patient's Home. Significant Reduction Of Indirect Costs Incurred By Care Recipients and Unpaid Caregivers Together With a Total Adhesion To The Treatment Schedule and Same Safety

Francesco Iuliano, MD, Eleonora Iuliano, MD, Alessia Perricelli, MD, Angelo Pomillo, MD, Maria Luci, MD, Gianluca Cervo

Blood (2013) 122 (21): 5587.

https://doi.org/10.1182/blood.V122.21.5587.5587

Published: 2013

Journal Articles

Senior Labor Study: A New Definition Of Normal Hemoglobin Values In Older Healthy Individuals

Lorenz Risch, MD, MPH, Corina Risch, Pedro Medina, Urs Nydegger, Martin Risch, Jean-Francois Lambert

Blood (2013) 122 (21): 956.

https://doi.org/10.1182/blood.V122.21.956.956

Published: 2013

Journal Articles

Medicare Prescription Drug Coverage and Home Use of Erythropoiesis-Stimulating Agents for MDS-Associated Anemia: A Medicare-Database Analysis.

Amy J. Davidoff, M.S., Ph.D., Franklin Hendrick, B.S., Bruce C. Stuart, PhD, Amer M. Zeidan, MD, Rahul Shenolikar, PhD, Steven D. Gore, MD, Maria R. Baer, M.D.

Blood (2012) 120 (21): 3176.

https://doi.org/10.1182/blood.V120.21.3176.3176

Published: 2012

Journal Articles

Risk Factors for Venous Thromboembolism (VTE) Among Nursing Home Residents: A Population-Based Case Control Study

Cynthia L. Leibson, Ph.D., John A. Heit, M.D., Aneel Ashrani, MBBS, MSc, Kent R. Bailey, Ph.D., Tanya M. Petterson, MS, Carin Y Smith, BS

Blood (2010) 116 (21): 476.

https://doi.org/10.1182/blood.V116.21.476.476

Published: 2010

Journal Articles

Are Beta-Receptor and Angiotensin-Blocking Drugs Protective Against Venous Thromboembolism (VTE)? A Population Based Case-Control Study

Aneel A. Ashrani, MBBS, MSc, Wencheng Geng, Daniel J. Crusan, Tanya M. Petterson, Kent R. Bailey, PhD, Cynthia L. Leibson, PhD, John A. Heit, MD

Blood (2010) 116 (21): 5118.

https://doi.org/10.1182/blood.V116.21.5118.5118

Published: 2010

Journal Articles

Off-Label Use of Recombinant Factor VIIa in United States Hospitals: 2000-2008.

Aaron C. Logan, MD, PhD, Veronica Yank, MD, Randall S. Stafford, MD, PhD

Blood (2009) 114 (22): 67.

https://doi.org/10.1182/blood.V114.22.67.67

Published: 2009

NARROW

The Real World Experience Regarding the Safety of Rivaroxaban and Apixaban in Venous Thromboembolism Patients with High Bleeding Risk

The Role of Demographic and Social Factors on Decision Making in Patients with Relapsed and Refractory Multiple Myeloma Treated By Ixazomib, Lenalidomide and Dexamethasone

Predictors of Transfer to Different Facility at Discharge in Patients Admitted with Hematologic Malignancy: A Nationwide Inpatient Sample (NIS) Database Analysis

Management of Cerebral Vein Thrombosis in a Canadian Tertiary Hospital

Health Care Utilization and Costs Among Patients with Chronic Myeloid Leukemia Using Tyrosine Kinase Inhibitors

Patient with Myeloma Who Develops Thrombotic Microangiopathy without Hemolysis

Assisted Administration of Subcutaneous Rituximab to the Patient's Home. Significant Reduction of Indirect Costs Incurred By Care Recipients and Unpaid Caregivers Together with a Total Adherence to the Treatment Schedule and Same Safety

Predictors for Recurrent 30-Day Unplanned Readmissions in Patients with Hematologic Malignancies

Comparison of Disposition and Complications in Geriatric (≥ 65 years) and Non-Geriatric (50-64 years) Cancer Patients Receiving Hematopoietic Stem Cell Transplantation

A Rapid Desensitization Program Is a Viable Therapeutic Option in the Management of Immunomodulating Agent-Related Hypersensitivity Reactions in Patients with Plasma Cell Disorders

Risk Factors for Early Death after Immunochemotherapy in Older Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Examination of the Prognosis and Health-Related Quality of Life of Elderly Patients with Malignant Lymphoma

Spectrum of Cerebrovascular Disease in Multiple Myeloma Patients Undergoing Chemotherapy

Using the Rothman Index to Predict Discharge and Readmission Rates in an Inpatient Hematology Unit

Assisted Administration Of Subcutaneous 5-Azacytidine to The Patient's Home. Significant Reduction Of Indirect Costs Incurred By Care Recipients and Unpaid Caregivers Together With a Total Adhesion To The Treatment Schedule and Same Safety

Senior Labor Study: A New Definition Of Normal Hemoglobin Values In Older Healthy Individuals

Medicare Prescription Drug Coverage and Home Use of Erythropoiesis-Stimulating Agents for MDS-Associated Anemia: A Medicare-Database Analysis.

Risk Factors for Venous Thromboembolism (VTE) Among Nursing Home Residents: A Population-Based Case Control Study

Are Beta-Receptor and Angiotensin-Blocking Drugs Protective Against Venous Thromboembolism (VTE)? A Population Based Case-Control Study

Off-Label Use of Recombinant Factor VIIa in United States Hospitals: 2000-2008.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only